知镜 Cognispect · 医学文献与研究工作台

Diffuse Large B-Cell Lymphoma Presenting in a Background of Rosai-Dorfman Disease.

Wu C, Meyer A, Tun AM.
Case reports in hematology · 2026-05-17 · PMID 42158929

文献摘要

Rosai-Dorfman disease (RDD) can present with lymphadenopathy. However, it is important to note that RDD can also coexist with hematologic malignancies, including non-Hodgkin lymphomas. We present a case of an older male patient with generalized lymphadenopathy who was first diagnosed with RDD. High-dose steroid therapy was rendered without a satisfactory response. Thus, the tissue specimens were re-examined, and the patient was found to have diffuse large B-cell lymphoma (DLBCL) in the background of RDD. The laboratory tests are notable for a slightly elevated serum lactate dehydrogenase (LDH) level. A positron emission tomography-computed tomography scan revealed generalized hypermetabolic lymphadenopathy above and below the diaphragm. A bone marrow biopsy showed normocellular marrow without evidence of DLBCL. The international prognostic index score was 3 (age > 60 years, elevated serum LDH level, and Stage III disease), indicating a high-intermediate risk disease. The patient was treated with six cycles of golcadomide in combination with R-Pola-CHP (rituximab, polatuzumab vedotin, cyclophosphamide, doxorubicin, and prednisone) for the underlying DLBCL, with resolution of both DLBCL and RDD. The disease remained in remission at the follow-up visit 9 months after completing the therapy. This case highlights the importance of recognizing underlying DLBCL in patients with RDD for optimal patient outcomes. Trial Registration: ClinicalTrials.gov identifier: NCT04884035.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。